Canada's fragrance allergen disclosure, and the 2026 dates that change it
Health Canada is phasing in fragrance allergen disclosure on the CNF and the label. Here is what List 1 and List 2 mean, and the two dates that decide when each one binds you.
Health Canada is phasing in fragrance allergen disclosure on the CNF and the label. Here is what List 1 and List 2 mean, and the two dates that decide when each one binds you.
Where Parfum and its broken-out allergens actually sit in your INCI list when the total scent load is small.
Why kills-germs wording on a soap label moves it out of cosmetic notification and into drug labeling territory.
How stretch mark cream wording decides whether you are filing a cosmetic notification or stepping into drug territory.
How to legally sell down existing inventory while new compliant labels roll into production, without a recall or a wasted pallet.
What Canada's List 1 fragrance allergen disclosure means for your CNF and label starting April 12, 2026, and how to check your formula now.
Why brightening claims can stay cosmetic while whitening or lightening language often signals a drug claim, with wording examples.
When EU Regulation 1223/2009 requires a stated product function on the label, with soap and serum examples showing where it applies.
Saying your serum treats acne, not just oily skin, can shift it out of cosmetic territory entirely. Here is where that line sits.
Why every MoCRA-covered cosmetic label needs a real domestic address, phone number, or electronic contact, and what actually satisfies it.
Salicylic acid sits on the Hotlist as a restricted ingredient, and going over its threshold changes both your filing and your label.
The testing and formulation reasoning that should sit behind any sensitive skin claim before it goes on a label.
Cosmetic fragrance allergen disclosure and candle labeling are governed by different rules entirely. Here is where the line sits.
Whether a cosmetic needs a durability date on its label often comes down to shelf life, and it interacts with PAO in ways worth understanding.
How INCI naming ties back to AICIS chemical identity for cosmetics sold in Australia, and where the two systems diverge.
What MoCRA's professional-use labeling statement actually says, and which salon and spa distribution setups genuinely need it.
Words like healing, eczema relief, or clears psoriasis on a soap label can quietly turn a cosmetic into an unregistered drug.
How the umbrella INCI term Parfum works alongside the named allergens Canada is phasing in under its 2026 disclosure lists.
Why saying your soap kills germs can turn it into a drug overnight, and what wording keeps it a cosmetic instead.
How coumarin's leave-on and rinse-off thresholds work in practice, using real percentage math a maker can follow.
Vegan and cruelty-free are not the same promise. Here is what a vegan claim actually covers and the animal-derived ingredients that quietly break it.
The discontinue-if-irritation and eye-contact caution language expected on mascaras, liners, and other eye-area cosmetics, explained plainly.
Any sun protection factor claim shifts a product out of cosmetic territory and into drug or natural health product rules, with different labeling entirely.
Why clove oil, geraniol, and linalool are not interchangeable on a label, and how to translate common allergen names into the INCI form regulators expect.